Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PANSY: EC-T vs PCb in Non-Triple Negative Breast Cancer
NCT04193059Phase 3Active, not recruiting
- Sponsor
- Fudan University
- Start
- Dec 2019
- Primary completion
- Jul 2026
- Modality
- DNA Intercalators/Alkylators, Cytokines & Interferons, Fc-Fusion Proteins
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of Paclitaxel Micelles for Injection and carboplatin in breast cancer, sponsored by Fudan University. Started Dec 2019; status: active, not recruiting.
02
Drugs
Paclitaxel Micelles for Injectioncarboplatin
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT04193059.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04193059.